SCHEMBL30723247

SCHEMBL30723247

CCCCNC(=O)[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)C(=O)O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FNTA P49354 1/20 0.45
FNTB P49356 1/20 0.45
NAAA Q02083 2/20 0.44
DPP7 Q9UHL4 2/20 0.43
EPHX1 P07099 4/20 0.42
METAP2 P50579 1/20 0.41
LMNA P02545 1/20 0.41
PAX8 Q06710 1/20 0.41
MEN1 O00255 1/20 0.41
USP2 O75604 1/20 0.41
ALDH1A1 P00352 1/20 0.41
MAPT P10636 1/20 0.41
KMT2A Q03164 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.40
ACHE P22303 1/20 0.40
RRM1 P23921 1/20 0.40
MMP2 P08253 1/20 0.40
PDE4A P27815 1/20 0.39
REN P00797 1/20 0.39
ALOX15 P16050 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27658905 0.95 FNTA (0.51) FNTAFNTBNAAADPP7EPHX1
SCHEMBL22388707 0.95 FNTA (0.51) FNTAFNTBNAAADPP7EPHX1
SCHEMBL20875810 0.93 FNTA (0.54) FNTAFNTBNAAADPP7EPHX1
SCHEMBL20875821 0.93 FNTA (0.54) FNTAFNTBNAAADPP7EPHX1
SCHEMBL20875767 0.93 FNTA (0.54) FNTAFNTBNAAADPP7EPHX1
SCHEMBL20876033 0.93 FNTA (0.54) FNTAFNTBNAAADPP7EPHX1
SCHEMBL20875808 0.93 FNTA (0.54) FNTAFNTBNAAADPP7EPHX1
SCHEMBL20875745 0.93 FNTA (0.54) FNTAFNTBNAAADPP7EPHX1
SCHEMBL20875764 0.93 FNTA (0.54) FNTAFNTBNAAADPP7EPHX1
SCHEMBL20875788 0.93 FNTA (0.54) FNTAFNTBNAAADPP7EPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260008801-A1 BIO-BASED SURFACTANTS DERIVED FROM CARBOHYDRATES COÖPERATIE KONINKLIJKE COSUN U.A. (NL) 2026-01-08 US claimed
EP-4540220-A1 BIO-BASED SURFACTANTS DERIVED FROM CARBOHYDRATES Coöperatie Koninklijke Cosun U.A. (NL) 2025-04-23 EP claimed
WO-2023242424-A1 BIO-BASED SURFACTANTS DERIVED FROM CARBOHYDRATES COÖPERATIE KONINKLIJKE COSUN U.A. (NL) 2023-12-21 WO claimed
US-20260008801-A1 BIO-BASED SURFACTANTS DERIVED FROM CARBOHYDRATES COÖPERATIE KONINKLIJKE COSUN U.A. (NL) 2026-01-08 US disclosed
EP-4540220-A1 BIO-BASED SURFACTANTS DERIVED FROM CARBOHYDRATES Coöperatie Koninklijke Cosun U.A. (NL) 2025-04-23 EP disclosed
WO-2023242424-A1 BIO-BASED SURFACTANTS DERIVED FROM CARBOHYDRATES COÖPERATIE KONINKLIJKE COSUN U.A. (NL) 2023-12-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260008801-A1 BIO-BASED SURFACTANTS DERIVED FROM CARBOHYDRATES CEL, SI, ACMSD FNTA 4703/4885FNTB 4046/4885NAAA 592/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.